Table 3.

Adenosine receptor gene expression levels in ciPTEC

		Ct values			Fold increase (2^ΔΔCt)
	Control	LPS	recAP	recAP + LPS	Control	LPS	recAP	recAP + LPS
A1	28.9 [28.4–30.6]	29.5 [29.3–30.1]	28.9 [28.1–29.8]	29.6 [28.9–29.9]	1 ± 0	0.6 ± 0.1	1.2 ± 0.2	0.7 ± 0.1
A2A	31.5 [30.6–33.0]	29.2 [29.0–30.4]	32.1 [31.4–32.8]	30.1 [29.4–30.3]	1 ± 0	4.1 ± 0.4#	0.8 ± 0.1	2.9 ± 0.2#, *
A2B	27.9 [27.1–29.3]	27.9 [27.7–28.8]	28.2 [27.6–29.2]	28.6 [27.7–28.7]	1 ± 0	0.8 ± 0.1	0.8 ± 0.1	0.7 ± 0.1
A3	36.3 [35.9–36.8]	35.9 [35.4–36.7]	36.9 [36.3–37.8]	36.8 [35.7–38.1]	1 ± 0	0.6 ± 0.2	1.3 ± 0.4	0.6 ± 0.1

Data are expressed as mean ± SEM, and median [25th percentile, 75th percentile], depending on the distribution of each parameter. Significant differences of the fold increase were estimated using one‐way ANOVA with Bonferroni post‐test. n = 5.

^# P < 0.05 compared with placebo

^* P < 0.05 compared with LPS.